---
figid: PMC10992617__40643_2022_569_Fig3_HTML
pmcid: PMC10992617
image_filename: 40643_2022_569_Fig3_HTML.jpg
figure_link: /pmc/articles/PMC10992617/figure/Fig3/
number: Fig. 3
figure_title: ''
caption: 'Schematic diagram of the biosynthesis of oxygenated taxanes with a heterologous
  MVA pathway. mvaE: acetoacetyl-CoA thiolase/HMG-CoA reductase gene; mvaS: HMG-CoA
  synthase gene; erg12: mevalonate kinase; erg8: phosphomevalonate kinase; erg19:
  mevalonate pyrophosphate decarboxylase; idi: IPP:DMAPP isomerase; GGPPS: geranylgeranyl
  pyrophosphate synthase; TS: taxadiene synthase; T5αOH-CPR: the fusion protein of
  taxadiene-5α-hydroxylase and Taxus-derived cytochrome P450 reductase; OCT: 5(12)-oxa-3(11)-cyclotaxane;
  iso-OCT: 5(13)-oxa-3(11)-cyclotaxane'
article_title: Construction of an Escherichia coli cell factory to synthesize taxadien-5α-ol,
  the key precursor of anti-cancer drug paclitaxel.
citation: Qing-Yang Wu, et al. Bioresour Bioprocess. 2022 Dec;9(1):82.
year: '2022'

doi: 10.1186/s40643-022-00569-5
journal_title: Bioresources and Bioprocessing
journal_nlm_ta: Bioresour Bioprocess
publisher_name: Springer Nature Singapore

keywords:
- Oxygenated taxanes
- Metabolic engineering
- Taxadiene-5α-hydroxylase
- Fusion protein
- Mevalonate pathway
- Paclitaxel
- Escherichia coli

---
